RELOYUS

Class [005]
Pharmaceutical preparations for use in the treatment of myelofibrosis, polycythemia vera, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries in the fields of oncology, immunology and inflammation; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system, namely hermatological tumors, solid tumors and inflammatory diseases namely inflammatory bowel diseases, inflammatory connective tissue diseases, chronic obstructive pulmonary disease, inflammatory diseases of the thyroid, pelvic inflammatory disease, arthritis.